BlackRock Health Sciences Trust (BME) Financials
BME Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 528.6 million | 20.5 million |
| Dec. 31, 2024 | 774.6 million | 6.0 million |
| June 30, 2024 | 625.3 million | 9.0 million |
| March 31, 2024 | 625.3 million | 9.0 million |
BME Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | 34.3 million | ? |
| Dec. 31, 2024 | 959340 | ? |
| June 30, 2024 | -6.7 million | ? |
| March 31, 2024 | 8.9 million | ? |
BME Net Income
| Date | Net Income |
|---|---|
| June 30, 2025 | -3.6 million |
| Dec. 31, 2024 | -22.5 million |
| June 30, 2024 | 45.9 million |
| March 31, 2024 | 23.0 million |
BME Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 39397 | - | - |
| Dec. 31, 2024 | 26.6 million | - | - |
| June 30, 2024 | 1139 | - | - |
| March 31, 2024 | 1139 | - | - |
BME Shares Outstanding
BME Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | - | - | 3.0 million | - |
| Dec. 31, 2024 | 5 | - | 3.4 million | - |
| June 30, 2024 | 3 | - | 3.2 million | - |
| March 31, 2024 | - | - | 1.6 million | - |
BME Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | 4.0 million | 2.8 million |
| Dec. 31, 2024 | 36.7 million | 3.3 million |
| June 30, 2024 | -383858 | 3.1 million |
| March 31, 2024 | 2.0 million | - |
BME
Price: $44.04
Dividend Yield: 7.21%
Forward Dividend Yield: 7.17%
Payout Ratio: 177.50%
Dividend Per Share: 3.15 USD
Earnings Per Share: -1.99 USD
P/E Ratio: -21.21
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Country: United States
Volume: 21500
Market Capitalization: 564.1 million
Average Dividend Frequency: 12
Years Paying Dividends: 22
DGR3: 6.40%
DGR5: 5.14%
DGR10: 4.28%
DGR20: 8.54%